CYP1A1, CYP2E1, and GSTM1 Gene polymorphisms and susceptibility to colorectal and gastric cancer among Lebanese

Genetic Testing and Molecular Biomarkers

Volumn 15, Issue 6, 2011, Pages 423-429

  Darazy, Mohamad ^a   Balbaa, Mahmoud ^a,b   Mugharbil, Anas ^c   Saeed, Hesham ^d   Sidani, Hassan ^c   Abdel Razzak, Ziad ^e  

^a BEIRUT ARAB UNIVERSITY   (Lebanon)

^b Alexandria University Faculty Of Science   (Egypt)

^c MAKASSED GENERAL HOSPITAL   (Lebanon)

^d ALEXANDRIA UNIVERSITY   (Egypt)

^e LEBANESE UNIVERSITY   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 2E1; GLUTATHIONE TRANSFERASE M1;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GASTROINTESTINAL CARCINOMA; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEBANON; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; STOMACH CANCER; TUMOR BIOPSY;

AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2E1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LEBANON; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS; STOMACH NEOPLASMS;

EID: 79959214377     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2010.0206     Document Type: Article

References (35)

1. Anwar WA, Abdel-Rahman SZ, El-Zein RA, et al. (1996) Genetic polymorphism of GSTM1, CYP2E1, and CYP2D6 in Egyptian bladder cancer patients. Carcinogenesis 17:1923-1929. (Pubitemid 26325384)
2. Atexs NA, Tamer L, Atexs C, et al. (2005) Glutathione S-transferase M1, T1, P1 genotypes and risk for development of colorectal cancer. Biochem Genet 43:149-163. (Pubitemid 40543712)
3. Bartsch H, Nair U, Risch A, et al. (2009) Genetic polymorphisms of CYP genes, alone or in Combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 9:3-28.
4. Bell DA, Taylor JA, Paulson DF, et al. (1993) Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen metabolism gene glutathione S-transferase Ml (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 85:1159-1164. (Pubitemid 23212283)
5. Boccia S, Sayed-Tabatabaei FA, Persiani R, et al. (2007) Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population. BMC Cancer 7:206.
6. Gao Y, Cao Y, Tan A, et al. (2010) Glutathione S-transferase M1 polymorphism and sporadic colorectal cancer risk: an updating meta-analysis and HuGE review of 36 case-control studies. Ann Epidemiol 20:108-121.
7. Garte S, Gaspari L, Alexandrie AK, et al. (2001) Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 10:1239-1248. (Pubitemid 34027754)
8. Gelboin H (1980) Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role of regulation of mixed-function oxidases and related enzymes. Physiol Rev 60:1107-1166.
9. Haufroid V, Buchet JP, Gardinal S, et al. (2002) Cytochrome P4502E1 phenotyping by the measurement of the chlorzoxazone metabolic ratio: assessment of its usefulness in workers exposed to styrene. Int Arch Occup Environ Health 75:453-458. (Pubitemid 36075138)
10. Kawajiri K, Watanabe J, Eguchi H, et al. (1995) Genetic polymorphisms of drug-metabolizing enzymes and lung cancer susceptibility. Pharmacogenetics 5:70-73.
11. Ketterer B, Harris JM, Talaska G, et al. (1992) The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environ Health Perspect 98:87-94. (Pubitemid 23061787)
12. Kiss I, Németh A, Bogner B, et al. (2004) Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer. Anticancer Res 24:3965-3970. (Pubitemid 40468694)
13. Landi MT, Bertazzi PA, Shields PG, et al. (1994) Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics 4:242-246. (Pubitemid 24337432)
14. Li H, Chen XL, Li HQ (2005) Polymorphism of CYPIA1 and GSTM1 genes associated with susceptibility of gastric cancer in Shandong Province of China. World J Gastroenterol 11:5757-5762. (Pubitemid 41662822)
15. Lucas D, Ménez C, Girre C, et al. (1995) Cytochrome P450 2E1 genotype and chlorzoxazone metabolism in healthy and alcoholic Caucasian subjects. Pharmacogenetics 5:298-304.
16. Martínez C, Mart́in F, Fernández JM, et al. (2006) Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans. Pharmacogenomics 7:711-718. (Pubitemid 44219401)
17. Parkin DM, Bray F, Ferlay J, et al. (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108. (Pubitemid 40372904)
18. Petersen DD, McKinney CE, lkeya K, et al. (1991) Human CYP1A1 gene: Cosegregation of the enzyme inducibility phenotype and an RFLP. Am J Hum Genet 48:720-725. (Pubitemid 21891616)
19. Piao JM, Shin MH, Kweon SS, et al. (2009) Glutathione-S-transferase (GSTM1, GSTT1) and the risk of gastrointestinal cancer in a Korean population. World J Gastroenterol 15:5716-5721.
20. Raunio H, Husgafvel-Pursiainen K, Anttila S, et al. (1995) Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility-a review. Gene 159:113-121.
21. *0 genotypes. Pharmacogenetics 8:109-118. (Pubitemid 28227318)
22. Saadat I, Saadat M (2001) Glutathione S-transferase M1 and T1 null genotypes and the risk of gastric and colorectal cancers. Cancer Lett 169:21-26. (Pubitemid 32532092)
23. Sambrook J, Fritsch ER, Maniatis T (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
24. Sgambato A, Campisi B, Zupa A, et al. (2002) Glutathione S-transferase (GST) polymorphisms as risk factors for cancer in a highly homogeneous population from southern Italy. Anticancer Res 22:3647-3652. (Pubitemid 36132844)
25. Shamseddine AI, Musallam KM (2010) Cancer Epidemiology in Lebanon. Middle East J Cancer 1:41-44.
26. Shi SR, Cote RJ, Wu L, et al. (2002) DNA extraction from archival formalin-fixed, paraffin-embedded tissue sections based on the antigen retrieval principle: heating under the influence of pH. J Histochem Cytochem 50:1005-1011. (Pubitemid 34827622)
27. Sivaraman L, Leatham MP, Yee J, et al. (1994) CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Res 54:3692-3695. (Pubitemid 24241180)
28. Slattery ML, Samowtiz W, Ma K, et al. (2004) CYP1A1, cigarette smoking, and colon and rectal cancer. Am J Epidemiol 160:842-852. (Pubitemid 39434768)
29. Tamer L, Ates NA, Ates C, et al. (2005) Glutathione S-transferase M1, T1 and P1 genetic polymorphisms, cigarette smoking and gastric cancer risk. Cell Biochem Funct 23:267-272. (Pubitemid 40992785)
30. Tanaka E, Terada M, Misawa S (2000) Cytochrome P450 2E1: its clinical and toxicological role. J Clin Pharm Ther 25:165-175. (Pubitemid 30495308)
31. Wang H, Zhou Y, Zhuang W, et al. (2010) Glutathione S-transferase M1 null genotype associated with gastric cancer among Asians. Dig Dis Sci 55:1824-1830.
32. Welfare M, Monesola Adeokun A, Bassendine MF, et al. (1999) Polymorphism in GSTP1, GSTM1, and susceptibility to colorectal cancer. Cancer Epidemiol Biomarkers Prev 8:289-292. (Pubitemid 29193898)
33. Wu MS, Chen CJ, Lin MT, et al. (2002) Genetic polymorphisms of cytochrome P450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan. Int J Colorectal Dis 17:338-343.
34. Ye Z, Parry JM (2002) Genetic polymorphisms in the cytochrome P450 1A1, glutathione S-transferase M1 and T1, and susceptibility to colon cancer. Teratog Carcinog Mutagen 22:385-392. (Pubitemid 34977234)
35. Zgheib NK, Mitri Z, Geryess E, et al. (2010) Cytochrome P4502E1 (CYP2E1) genetic polymorphisms in a Lebanese population: frequency distribution and association with morbid diseases. Genet Test Mol Biomarkers 14:393-397.